Endothelium-dependent hyperpolarizations: past beliefs and present facts - PubMed (original) (raw)
Review
Endothelium-dependent hyperpolarizations: past beliefs and present facts
Michel Félétou et al. Ann Med. 2007.
Free article
Abstract
Endothelium-dependent relaxations are attributed to the release of various factors, such as nitric oxide, carbon monoxide, reactive oxygen species, adenosine, peptides and arachidonic acid metabolites derived from the cyclooxygenases, lipoxygenases, and cytochrome P450 monooxygenases pathways. The hyperpolarization of the smooth muscle cell can contribute to or be an integral part of the mechanisms underlying the relaxations elicited by virtually all these endothelial mediators. These endothelium-derived factors can activate different families of K(+) channels of the vascular smooth muscle. Other events associated with the hyperpolarization of both the endothelial and the vascular smooth muscle cells (endothelium-derived hyperpolarizing factor (EDHF)-mediated responses) contribute also to endothelium-dependent relaxations. These responses involve an increase in the intracellular Ca(2+) concentration of the endothelial cells followed by the opening of Ca(2+)-activated K(+) channels of small and intermediate conductance and the subsequent hyperpolarization of these cells. Then, the endothelium-dependent hyperpolarization of the underlying smooth muscle cells can be evoked by direct electrical coupling through myoendothelial junctions and/or the accumulation of K(+) ions in the intercellular space between the two cell types. These various mechanisms are not necessarily mutually exclusive and, depending on the vascular bed and the experimental conditions, can occur simultaneously or sequentially, or also may act synergistically.
Similar articles
- EDHF: an update.
Félétou M, Vanhoutte PM. Félétou M, et al. Clin Sci (Lond). 2009 Jul 16;117(4):139-55. doi: 10.1042/CS20090096. Clin Sci (Lond). 2009. PMID: 19601928 Review. - Endothelium-derived hyperpolarizing factor: where are we now?
Félétou M, Vanhoutte PM. Félétou M, et al. Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1215-25. doi: 10.1161/01.ATV.0000217611.81085.c5. Epub 2006 Mar 16. Arterioscler Thromb Vasc Biol. 2006. PMID: 16543495 Review. - Endothelium-dependent hyperpolarization of vascular smooth muscle cells.
Félétou M, Vanhoutte PM. Félétou M, et al. Acta Pharmacol Sin. 2000 Jan;21(1):1-18. Acta Pharmacol Sin. 2000. PMID: 11263241 Review. - Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease.
Coleman HA, Tare M, Parkington HC. Coleman HA, et al. Clin Exp Pharmacol Physiol. 2004 Sep;31(9):641-9. doi: 10.1111/j.1440-1681.2004.04053.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15479173 Review. - Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel.
Si H, Heyken WT, Wölfle SE, Tysiac M, Schubert R, Grgic I, Vilianovich L, Giebing G, Maier T, Gross V, Bader M, de Wit C, Hoyer J, Köhler R. Si H, et al. Circ Res. 2006 Sep 1;99(5):537-44. doi: 10.1161/01.RES.0000238377.08219.0c. Epub 2006 Jul 27. Circ Res. 2006. PMID: 16873714
Cited by
- Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.
Ohta M, Toyama K, Gutterman DD, Campbell WB, Lemaître V, Teraoka R, Miura H. Ohta M, et al. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):629-36. doi: 10.1161/ATVBAHA.112.300600. Epub 2013 Jan 3. Arterioscler Thromb Vasc Biol. 2013. PMID: 23288168 Free PMC article. - Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
Morales P, Garneau L, Klein H, Lavoie MF, Parent L, Sauvé R. Morales P, et al. J Gen Physiol. 2013 Jul;142(1):37-60. doi: 10.1085/jgp.201210933. J Gen Physiol. 2013. PMID: 23797421 Free PMC article. - Adenosine relaxation in isolated rat aortic rings and possible roles of smooth muscle Kv channels, KATP channels and A2a receptors.
Arsyad A, Dobson GP. Arsyad A, et al. BMC Pharmacol Toxicol. 2016 May 23;17(1):23. doi: 10.1186/s40360-016-0067-8. BMC Pharmacol Toxicol. 2016. PMID: 27211886 Free PMC article. - Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension?
Berenyiova A, Bernatova I, Zemancikova A, Drobna M, Cebova M, Golas S, Balis P, Liskova S, Valaskova Z, Krskova K, Zorad S, Dayar E, Cacanyiova S. Berenyiova A, et al. Biomedicines. 2021 Dec 24;10(1):38. doi: 10.3390/biomedicines10010038. Biomedicines. 2021. PMID: 35052717 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous